GSK-105245

Study Sponsor: GSK

Study Title

Booster Vaccination Study to Assess Immunogenicity & Safety of a Dose of GSK Biologicals' Mencevax™ ACWY & 1/5th of a Dose of Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

Medicine or Vaccine (generic name)

Meningococcal Serogroups A, C, W-135 and Y Vaccine

Sponsor Identification Number

105245

Trial Registry Identification Number(#'s)

NCT00291343

Medical Condition

Infections, Meningococcal

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=105239 (mth24-30)

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00291343

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a follow-up study to 100478. The results are summarised with study 105239 on the GSK Study Register. An annotated case report form is not available for this study. A blank case report form will be provided

Date Added to this Site

October 2014